• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD EVOLUTION® BILIARY CONTROLLED-RELEASE STENT - UNCOVERED; FGE CATHETER, BILIARY, DIAGNOSTIC - BILIARY STENT - METAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD EVOLUTION® BILIARY CONTROLLED-RELEASE STENT - UNCOVERED; FGE CATHETER, BILIARY, DIAGNOSTIC - BILIARY STENT - METAL Back to Search Results
Catalog Number EVO-10-11-6-B
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Abdominal Pain (1685); Itching Sensation (1943); Vomiting (2144); Obstruction/Occlusion (2422)
Date of Event 04/14/2016
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Device evaluation: the evo-10-11-6-b device of lot number: c1057497 involved in this complaint was not returned for evaluation.With the information provided, a document-based investigation was conducted.This file was created in response to the (b)(4) study.Manufacturing records review: prior to distribution all devices are subjected to a visual inspection and functional inspection to ensure device integrity.A review of the manufacturing records did not reveal any discrepancies that could have contributed to this complaint issue.Instructions for use and/label review: it should be noted that the instructions for use (ifu0056) lists ¿stent occlusion¿ as a potential adverse event.There is no evidence to suggest that the customer did not follow the instructions for use.Image review: an image was not returned for evaluation.Root cause analysis: a definitive root cause could not be determined.A possible root cause can be attributed to patient pre-existing conditions and/or a known potential adverse event.From the study it is known that the patient had ampullary cancer, the cause of the obstruction was reported to be due to tissue or tumor ingrowth with progression of cancer listed as the cause or contributing factor of this event.Also, as previously noted, ¿stent occlusion¿ is listed as a potential adverse event in the ifu.Confirmation of complaint: the complaint is confirmed based on customer and/or rep testimony.Confirmed quantity of 01 x used device.Corrective action/correction: complaints of this nature will continue to be monitored for similar events.Summary of investigation: according to the initial reporter, the stent was implanted on (b)(6) 2014.The patient experienced abdominal pain, itching and vomiting due to recurrent biliary obstruction 105 days post procedure.The patient required antibiotics and endoscopic intervention as a result of this occurrence, a plastic stent was placed inside the study stent.It was reported that the patient recovered/stabilized following this.A second case of obstruction was reported on (b)(6) 2015, this obstruction was not related to the evo-10-11-6-b stent.Patient death was reported on (b)(6) 2016, the cause of death was unknown, from medical advisor input the death was due to progression of cancer.
 
Event or Problem Description
Supplemental report is being submitted due to the completion of the investigation on 06-dec-2024.
 
Additional Manufacturer Narrative
Investigation is still pending, a follow up mdr will be submitted to include the investigation conclusions.
 
Event or Problem Description
(b)(6) 2014 date of first implant procedure with evolution® biliary stent system-uncovered evo-10-11-6-b, lot c1057497 in common bile duct.No adverse events related to the procedure.Re-current biliary obstructions (b)(6) 2015.Due to tissue or tumor ingrowth.Patient presented with abdominal pain, itching and vomiting.Intervention performed 105 days post procedure.Treatment endoscopic intervention plastic stent inside study stent with antibiotics.The site determined the event to not be related to the study device or procedure, related to progression of cancer.Re-current biliary obstructions (b)(6) 2015.Due to tissue or tumor ingrowth.Treatment endoscopic intervention change of biliary prosthesis to a new uncovered metallic prosthesis with antibiotics.The site determined the event to not be related to the study device or procedure, related to progression of cancer.Patient death (b)(6) 2016.Unknown cause of death.Both reinterventions were noted to be successful.On (b)(6) 2016, the patient died.The cause of death was unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVOLUTION® BILIARY CONTROLLED-RELEASE STENT - UNCOVERED
Common Device Name
FGE CATHETER, BILIARY, DIAGNOSTIC - BILIARY STENT - METAL
Manufacturer (Section D)
COOK IRELAND LTD
o halloran road
limerick
Manufacturer (Section G)
COOK IRELAND LTD
o halloran road
national technology park
limerick
Manufacturer Contact
sinead o'leary
o halloran road
national technology park
limerick 
MDR Report Key20783646
Report Number3001845648-2024-00692
Device Sequence Number5051853
Product Code FGE
UDI-Device Identifier10827002231280
UDI-Public(01)10827002231280(17)161125(10)C1057497
Combination Product (Y/N)N
PMA/510(K) Number
K121430
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Study
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/06/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue NumberEVO-10-11-6-B
Device Lot NumberC1057497
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date04/14/2016
Event Location Hospital
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 10/30/2024
Supplement Date Received by Manufacturer10/30/2024
Initial Report FDA Received Date11/26/2024
Supplement Report FDA Received Date12/13/2024
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age80 YR
Patient SexMale
Patient Weight69 KG
-
-